Search

everythinglearnresearchcommunity

for

Search:↓

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Many patients on new leukemia drugs had mild to moderate skin reactions.

A woman's hair turned white after taking a cancer drug called dasatinib.

Nilotinib can cause generalized keratosis pilaris.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

The compound 4c showed strong potential as an anticancer agent.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.